Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 50, Issue 6 (Jun 2012)

Issues

Linking preeclampsia and cardiovascular disease later in life

Yves Giguère
  • Corresponding author
  • Centre Hospitalier Universitaire de Québec, Québec City, QC, Canada
  • Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Quebec City, QC, Canada
  • Email:
/ Marc Charland
  • Centre Hospitalier Universitaire de Québec, Québec City, QC, Canada
/ Sébastien Thériault
  • Centre Hospitalier Universitaire de Québec, Québec City, QC, Canada
/ Emmanuel Bujold
  • Centre Hospitalier Universitaire de Québec, Québec City, QC, Canada
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, Québec City, QC, Canada
/ Mélissa Laroche
  • Centre Hospitalier Universitaire de Québec, Québec City, QC, Canada
/ François Rousseau
  • Centre Hospitalier Universitaire de Québec, Québec City, QC, Canada
  • Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Quebec City, QC, Canada
/ Julie Lafond
  • Centre de Recherche BioMed and Département des Sciences Biologiques, UQAM, Montréal, QC, Canada
/ Jean-Claude Forest
  • Centre Hospitalier Universitaire de Québec, Québec City, QC, Canada
  • Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Quebec City, QC, Canada
Published Online: 2011-11-23 | DOI: https://doi.org/10.1515/cclm.2011.764

Abstract

Preeclampsia (PE), which is defined as new onset hypertension after 20 weeks of pregnancy accompanied by proteinuria, is characterized by inadequate placentation, oxidative stress, inflammation and widespread endothelial dysfunction. A link between PE and long-term risk of cardiovascular disease (CVD) was suggested by retrospective studies, which found that PE was associated with a 2–3-fold risk of CVD later in life, with a 5–7-fold risk in the case of severe and/or early-onset PE. Recently, meta-analyses and prospective studies have confirmed the association between PE and the emergence of an unfavorable CVD risk profile, in particular a 3–5-fold increased prevalence of the metabolic syndrome only 8 years after the index pregnancy. PE and CVD share many risk factors, including obesity, hypertension, dyslipidemia, hypercoagulability, insulin resistance and both entities are characterized by endothelial dysfunction. PE and CVD are complex traits sharing common risk factors and pathophysiological processes, but the genetic link between both remains to be elucidated. However, recent evidence suggests that genetic determinants associated with the metabolic syndrome, inflammation and subsequent endothelial dysfunction are involved. As the evidence now supports that PE represents a risk factor for the emergence of the metabolic syndrome and CVD later in life, the importance of long-term follow-up assessment of CVD risk beginning early in women with a history of PE must be considered and translated into new preventive measures.

Keywords: genetic determinants; long-term risk of cardiovascular disease; metabolic syndrome; preeclampsia

About the article

Corresponding author: Yves Giguère, CRCHUQ, Hôpital Saint-François d’Assise, 10, rue de l’Espinay, Québec City, QC, G1L 3L5, Canada Phone: +1-418-525-4444 ext. 53712, Fax: +1-418-525-4195


Received: 2011-06-30

Accepted: 2011-09-05

Published Online: 2011-11-23

Published in Print: 2012-06-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm.2011.764. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Mette-Elise Estensen, Guro Grindheim, Espen W. Remme, Kristin Godang, Tore Henriksen, Pål Aukrust, Svend Aakhus, Lars Gullestad, and Thor Ueland
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2015
[2]
E. Conti, L. Zezza, E. Ralli, D. Caserta, M.B. Musumeci, M. Moscarini, C. Autore, and M. Volpe
Cytokine & Growth Factor Reviews, 2013, Volume 24, Number 5, Page 411
[3]
Janet Y. Uriu-Adams, Sarah G. Obican, and Carl L. Keen
Birth Defects Research Part C: Embryo Today: Reviews, 2013, Volume 99, Number 1, Page 24
[4]
M. P. Johnson, S. P. Brennecke, C. E. East, T. D. Dyer, L. T. Roten, J. M. Proffitt, P. E. Melton, M. H. Fenstad, T. Aalto-Viljakainen, K. Makikallio, S. Heinonen, E. Kajantie, J. Kere, H. Laivuori, R. Austgulen, J. Blangero, E. K. Moses, A. Pouta, K. Kivinen, E. Ekholm, R. Hietala, S. Sainio, T. Saisto, J. Uotila, M. Klemetti, A. Inkeri Lokki, L. Georgiadis, E. Huovari, E. Kortelainen, S. Leminen, A. Lahdesmaki, S. Mehtala, and C. Salmen
Molecular Human Reproduction, 2013, Volume 19, Number 7, Page 423
[5]
Egle Bytautiene, Nataliya Bulayeva, Geeta Bhat, Li Li, Kevin P. Rosenblatt, and George R. Saade
American Journal of Obstetrics and Gynecology, 2013, Volume 208, Number 5, Page 388.e1
[6]
Marco Scioscia, S. Ananth Karumanchi, Debra Goldman-Wohl, and Pierre-Yves Robillard
Journal of Reproductive Immunology, 2015, Volume 108, Page 42
[8]
Phoebe A. Stapleton, Cody E. Nichols, Jinghai Yi, Carroll R. McBride, Valerie C. Minarchick, Danielle L. Shepherd, John M. Hollander, and Timothy R. Nurkiewicz
Nanotoxicology, 2014, Page 1
[9]
José T. Drost, Angela H.E.M. Maas, Suzanne Holewijn, Leo A.B. Joosten, Jim van Eyck, Yvonne T. van der Schouw, and Jacqueline de Graaf
Atherosclerosis, 2014, Volume 237, Number 1, Page 117

Comments (0)

Please log in or register to comment.
Log in